SEC Form 4 · accession 0001595202-26-000002
NeuroPace Inc · NPCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa Andrade
Director
Period of report
Jun 5, 2026
Accepted (ET)
Jun 5, 2026 · 5:09 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001528287
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2026 | A | 2,890 | $0.00 | A | 2,890 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $15.74 | Jun 5, 2026 | A | 5,368 | A | — | Jun 4, 2036 | Common Stock | 5,368 | 5,368 | D |
Explanation of responses
- F1The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date.
- F2The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.